RE:RE:RE:RE:RE:Merck USA (MSD) acquires Phase 2 biotech for US$ 10.8 Bln.Merck’s $10.8 billion buyout of Prometheus Biosciences can proceed after the FTC's waiting period expired on Monday May 23, 2023, meaning the companies can proceed to close the deal, according to an SEC filing.
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001718852/000119312523151010/d483093d8k.htm
https://endpts.com/mercks-10-8b-prometheus-buyout-can-proceed-after-antitrust-review/